title: [Suspected itchy rash secondary to lenalidomide].
authors.affiliation: Servicio de Farmacia. Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón.. vicente.escudero@salud.madrid.org.
authors.forename: Vicente
authors.initials: V
authors.lastname: Escudero-Vilaplana
authors.affiliation: Instituto de Investigación Sanitaria Gregorio Marañón. Servicio de Hematología. Hospital General Universitario Gregorio Marañón. Madrid. España.. vicente.escudero@salud.madrid.org.
authors.forename: Santiago
authors.initials: S
authors.lastname: Osorio Prendes
authors.affiliation: Servicio de Farmacia. Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón.. vicente.escudero@salud.madrid.org.
authors.forename: María
authors.initials: M
authors.lastname: Sanjurjo Sáez
mesh_terms: D000368:Aged; D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D003875:Drug Eruptions / Q000188:drug therapy* / Q000209:etiology; D005076:Exanthema / Q000188:drug therapy* / Q000209:etiology*; D005260:Female; D006801:Humans; D000077269:Lenalidomide; D011241:Prednisone / Q000627:therapeutic use; D013792:Thalidomide / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D020533:Angiogenesis Inhibitors; D000893:Anti-Inflammatory Agents; D013792:Thalidomide; D000077269:Lenalidomide; D011241:Prednisone